» Articles » PMID: 27796633

The Need for an Integrated Patient Navigation Pathway to Improve Access to Colonoscopy After Positive Fecal Immunochemical Testing: A Safety-Net Hospital Experience

Overview
Publisher Springer
Specialty Public Health
Date 2016 Nov 1
PMID 27796633
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Colorectal cancer (CRC) is a leading cause of cancer-related deaths in the United States. Delays in access to colonoscopy following positive fecal immunochemical test (FIT) contribute to increased CRC incidence and mortality. To evaluate intervals from positive FIT result to receipt of colonoscopy among underserved safety-net populations. We retrospectively evaluated all average CRC risk adults who had positive FIT results from 2012 to 2015 at an ethnically diverse safety-net hospital system. Interval from positive FIT to receipt of colonoscopy was evaluated with Kaplan Meier methods and multivariate Cox proportional hazards models. Among 467 patients with positive FIT (48.4 % men, 39.5 % black, 22.5 % white, 17.4 % Asian, 9.7 % Hispanic, mean age 59.5 ± 9.8 years), mean time from positive FIT to receipt of colonoscopy was 220.5 days (SD 158.5). Compared to men, there was a trend towards longer time from FIT positive to colonoscopy among women (237.1 vs. 198.7 days, p = 0.07). No race/ethnicity-specific disparities in time to colonoscopy were observed. Compared to 2012-2013, there was a 27.2 % reduction in time from FIT positive to colonoscopy in 2014-2015 (173.9 vs. 238.8 days, p < 0.01). Among patients undergoing colonoscopy, 46.3 % had adenomatous polyps, 27.4 % had high risk adenomatous polyps, and 5.6 % had CRC. Among an ethnically diverse safety-net hospital system, improvements in access to colonoscopy after positive FIT were observed. However, patients still waited nearly 6 months from time of positive FIT to undergoing colonoscopy. Delays in receipt of colonoscopy are complex and reflect system-level and individual patient-level barriers.

Citing Articles

Reach and effectiveness of a centralized navigation program for patients with positive fecal immunochemical tests requiring follow-up colonoscopy.

OLeary M, Reuland D, Randolph C, Ferrari R, Brenner A, Wheeler S Prev Med Rep. 2023; 34:102211.

PMID: 37214164 PMC: 10196769. DOI: 10.1016/j.pmedr.2023.102211.


Equitable Implementation of Mailed Stool Test-Based Colorectal Cancer Screening and Patient Navigation in a Safety Net Health System.

Scott R, Chang P, Kluz N, Baykal-Caglar E, Agrawal D, Pignone M J Gen Intern Med. 2022; 38(7):1631-1637.

PMID: 36456842 PMC: 10212848. DOI: 10.1007/s11606-022-07952-0.


Colonoscopy Following an Abnormal Fecal Test Result from an Annual Colorectal Cancer Screening Program in a Federally Qualified Health Center.

Escaron A, Garcia J, Petrik A, Ruiz E, Nyongesa D, Thompson J J Prim Care Community Health. 2022; 13:21501319221138423.

PMID: 36448466 PMC: 9716593. DOI: 10.1177/21501319221138423.


Follow-up colonoscopy after an abnormal stool-based colorectal cancer screening result: analysis of steps in the colonoscopy completion process.

Coronado G, Kihn-Stang A, Slaughter M, Petrik A, Thompson J, Rivelli J BMC Gastroenterol. 2021; 21(1):356.

PMID: 34583638 PMC: 8477359. DOI: 10.1186/s12876-021-01923-1.


Implementing a multilevel intervention to accelerate colorectal cancer screening and follow-up in federally qualified health centers using a stepped wedge design: a study protocol.

Kim K, Polite B, Hedeker D, Liebovitz D, Randal F, Jayaprakash M Implement Sci. 2020; 15(1):96.

PMID: 33121536 PMC: 7599111. DOI: 10.1186/s13012-020-01045-4.


References
1.
Lumpkins C, Cupertino P, Young K, Daley C, Yeh H, Greiner K . Racial/Ethnic Variations in Colorectal Cancer Screening Self-Efficacy, Fatalism and Risk Perception in a Safety-Net Clinic Population: Implications for Tailored Interventions. J Community Med Health Educ. 2013; 3. PMC: 3826433. DOI: 10.4172/2161-0711.1000196. View

2.
Chubak J, Garcia M, Burnett-Hartman A, Zheng Y, Corley D, Halm E . Time to Colonoscopy after Positive Fecal Blood Test in Four U.S. Health Care Systems. Cancer Epidemiol Biomarkers Prev. 2016; 25(2):344-50. PMC: 4767632. DOI: 10.1158/1055-9965.EPI-15-0470. View

3.
Humphrey L, Shannon J, Partin M, OMalley J, Chen Z, Helfand M . Improving the follow-up of positive hemoccult screening tests: an electronic intervention. J Gen Intern Med. 2011; 26(7):691-7. PMC: 3138585. DOI: 10.1007/s11606-011-1639-3. View

4.
Bibbins-Domingo K, C Grossman D, Curry S, Davidson K, Epling Jr J, Garcia F . Screening for Colorectal Cancer: US Preventive Services Task Force Recommendation Statement. JAMA. 2016; 315(23):2564-2575. DOI: 10.1001/jama.2016.5989. View

5.
Correia A, Rabeneck L, Baxter N, Paszat L, Sutradhar R, Yun L . Lack of follow-up colonoscopy after positive FOBT in an organized colorectal cancer screening program is associated with modifiable health care practices. Prev Med. 2015; 76:115-22. DOI: 10.1016/j.ypmed.2015.03.028. View